Scholarlink

<p><i>N</i><sup>6</sup>-methyladenosine (m<sup>6</sup>A), the most abundant internal RNA modification in humans, regulates most aspects of RNA processing. Prostate cancer is characterized by widespread transcriptomic dysregulation; therefore, we characterized the m<sup>6</sup>A landscape of 162 localized prostate tumors with matched DNA, RNA and protein profiling. m<sup>6</sup>A abundance varied dramatically across tumors, with global patterns emerging via complex germline–somatic cooperative regulation. Individual germline polymorphisms regulated m<sup>6</sup>A abundance, cooperating with somatic mutation of cancer driver genes and m<sup>6</sup>A regulators. The resulting complex patterns were associated with prognostic clinical features and established the biomarker potential of global and locus-specific m<sup>6</sup>A patterns. Tumor hypoxia dysregulates m<sup>6</sup>A profiles, bridging prior genomic and proteomic observations. Specific m<sup>6</sup>A sites, such as those in <i>VCAN</i>, drive disease aggression, associating with poor outcomes, tumor growth and metastasis. m<sup>6</sup>A dysregulation is thus associated with key events in the natural history of prostate cancer: germline risk, microenvironmental dysregulation, somatic mutation and metastasis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The landscape of N6-methyladenosine in localized primary prostate cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月24日

查看全文
  • Xin Xu,
  • Helen Zhu,
  • Rupert Hugh-White,
  • Julie Livingstone,
  • Stefan Eng,
  • Nicole Zeltser,
  • Yujuan Wang,
  • Kinga Pajdzik,
  • Sujun Chen,
  • Kathleen E. Houlahan,
  • Wenqin Luo,
  • Shun Liu,
  • Xi Xu,
  • Minzhi Sheng,
  • Wang Yuan Guo,
  • Jaron Arbet,
  • Yuxi Song,
  • Miranda Wang,
  • Yong Zeng,
  • Shiyan Wang,
  • Guanghui Zhu,
  • Tingxiao Gao,
  • Wei Chen,
  • Xinpei Ci,
  • Wenjie Xu,
  • Kexin Xu,
  • Michele Orain,
  • Valerie Picard,
  • Helene Hovington,
  • Alain Bergeron,
  • Louis Lacombe,
  • Bernard Têtu,
  • Yves Fradet,
  • Mathieu Lupien,
  • Gong-Hong Wei,
  • Marianne Koritzinsky,
  • Robert G. Bristow,
  • Neil E. Fleshner,
  • Xue Wu,
  • Yang Shao,
  • Chuan He,
  • Alejandro Berlin,
  • Theodorus van der Kwast,
  • Hon Leong,
  • Paul C. Boutros,
  • Housheng Hansen He

摘要

N6-methyladenosine (m6A), the most abundant internal RNA modification in humans, regulates most aspects of RNA processing. Prostate cancer is characterized by widespread transcriptomic dysregulation; therefore, we characterized the m6A landscape of 162 localized prostate tumors with matched DNA, RNA and protein profiling. m6A abundance varied dramatically across tumors, with global patterns emerging via complex germline–somatic cooperative regulation. Individual germline polymorphisms regulated m6A abundance, cooperating with somatic mutation of cancer driver genes and m6A regulators. The resulting complex patterns were associated with prognostic clinical features and established the biomarker potential of global and locus-specific m6A patterns. Tumor hypoxia dysregulates m6A profiles, bridging prior genomic and proteomic observations. Specific m6A sites, such as those in VCAN, drive disease aggression, associating with poor outcomes, tumor growth and metastasis. m6A dysregulation is thus associated with key events in the natural history of prostate cancer: germline risk, microenvironmental dysregulation, somatic mutation and metastasis.